Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 5.08340826 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.08340826 |
3 | CENP-A containing nucleosome assembly (GO:0034080) | 4.69051194 |
4 | fatty acid elongation (GO:0030497) | 4.64178866 |
5 | protein neddylation (GO:0045116) | 4.61128598 |
6 | chromatin remodeling at centromere (GO:0031055) | 4.58489436 |
7 | axon ensheathment in central nervous system (GO:0032291) | 4.57527973 |
8 | central nervous system myelination (GO:0022010) | 4.57527973 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.51957457 |
10 | L-phenylalanine metabolic process (GO:0006558) | 4.51957457 |
11 | purine nucleobase biosynthetic process (GO:0009113) | 4.27895695 |
12 | establishment of integrated proviral latency (GO:0075713) | 4.18572559 |
13 | IMP biosynthetic process (GO:0006188) | 4.03359498 |
14 | protein localization to kinetochore (GO:0034501) | 3.94599129 |
15 | DNA ligation (GO:0006266) | 3.88554702 |
16 | histone exchange (GO:0043486) | 3.84342292 |
17 | proteasome assembly (GO:0043248) | 3.78364596 |
18 | aromatic amino acid family catabolic process (GO:0009074) | 3.77834023 |
19 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.71617702 |
20 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.71601396 |
21 | DNA replication-independent nucleosome organization (GO:0034724) | 3.71601396 |
22 | protein localization to chromosome, centromeric region (GO:0071459) | 3.64519414 |
23 | dicarboxylic acid catabolic process (GO:0043649) | 3.61769149 |
24 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.60482396 |
25 | mitotic metaphase plate congression (GO:0007080) | 3.60275642 |
26 | neutrophil activation involved in immune response (GO:0002283) | 3.53836850 |
27 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.52708266 |
28 | nuclear pore complex assembly (GO:0051292) | 3.49042852 |
29 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.47793352 |
30 | metaphase plate congression (GO:0051310) | 3.46992818 |
31 | DNA strand elongation (GO:0022616) | 3.45126764 |
32 | IMP metabolic process (GO:0046040) | 3.44431213 |
33 | nucleobase biosynthetic process (GO:0046112) | 3.43095361 |
34 | aspartate family amino acid catabolic process (GO:0009068) | 3.42212671 |
35 | very long-chain fatty acid metabolic process (GO:0000038) | 3.42088827 |
36 | coenzyme catabolic process (GO:0009109) | 3.41417086 |
37 | establishment of viral latency (GO:0019043) | 3.38317877 |
38 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.37572328 |
39 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.35960176 |
40 | negative regulation of ligase activity (GO:0051352) | 3.35960176 |
41 | glutamate metabolic process (GO:0006536) | 3.34675516 |
42 | establishment of chromosome localization (GO:0051303) | 3.34025349 |
43 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.32206346 |
44 | bile acid biosynthetic process (GO:0006699) | 3.32120604 |
45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.31942076 |
46 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.31810490 |
47 | negative regulation of sister chromatid segregation (GO:0033046) | 3.31810490 |
48 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.31810490 |
49 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.31810490 |
50 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.31810490 |
51 | spindle checkpoint (GO:0031577) | 3.31563036 |
52 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.30717783 |
53 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.30483050 |
54 | L-amino acid import (GO:0043092) | 3.28841777 |
55 | mitotic spindle checkpoint (GO:0071174) | 3.28239225 |
56 | mitotic G2/M transition checkpoint (GO:0044818) | 3.26874298 |
57 | synaptic vesicle exocytosis (GO:0016079) | 3.25360895 |
58 | negative regulation of chromosome segregation (GO:0051985) | 3.21500718 |
59 | nuclear pore organization (GO:0006999) | 3.16317880 |
60 | C4-dicarboxylate transport (GO:0015740) | 3.16140713 |
61 | mitotic spindle assembly checkpoint (GO:0007094) | 3.15147166 |
62 | formation of translation preinitiation complex (GO:0001731) | 3.14760217 |
63 | ribosome assembly (GO:0042255) | 3.14414169 |
64 | glutamate secretion (GO:0014047) | 3.12938238 |
65 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.12418528 |
66 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.12418528 |
67 | spindle assembly checkpoint (GO:0071173) | 3.12343587 |
68 | presynaptic membrane assembly (GO:0097105) | 3.09823599 |
69 | DNA replication checkpoint (GO:0000076) | 3.09420466 |
70 | cellular ketone body metabolic process (GO:0046950) | 3.08806983 |
71 | synapsis (GO:0007129) | 3.08145664 |
72 | gamma-aminobutyric acid transport (GO:0015812) | 3.07320334 |
73 | presynaptic membrane organization (GO:0097090) | 3.06747298 |
74 | neurotransmitter uptake (GO:0001504) | 3.06189229 |
75 | telomere maintenance via recombination (GO:0000722) | 3.04290449 |
76 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.04261982 |
77 | neuron cell-cell adhesion (GO:0007158) | 3.03772062 |
78 | cullin deneddylation (GO:0010388) | 3.03273417 |
79 | kinetochore organization (GO:0051383) | 3.02969112 |
80 | mitotic recombination (GO:0006312) | 3.02742147 |
81 | non-recombinational repair (GO:0000726) | 3.02647052 |
82 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.02647052 |
83 | response to methylmercury (GO:0051597) | 3.01395128 |
84 | negative regulation of neurotransmitter transport (GO:0051589) | 3.01192435 |
85 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.00619215 |
86 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.99120489 |
87 | cofactor catabolic process (GO:0051187) | 2.98735679 |
88 | meiotic chromosome segregation (GO:0045132) | 2.98082498 |
89 | DNA double-strand break processing (GO:0000729) | 2.96975071 |
90 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.94487867 |
91 | regulation of chromosome segregation (GO:0051983) | 2.94306181 |
92 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.94285815 |
93 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.94285815 |
94 | regulation of sister chromatid segregation (GO:0033045) | 2.94285815 |
95 | mitotic chromosome condensation (GO:0007076) | 2.90028342 |
96 | purine nucleotide salvage (GO:0032261) | 2.89847779 |
97 | acidic amino acid transport (GO:0015800) | 2.89834790 |
98 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.89784713 |
99 | lysine metabolic process (GO:0006553) | 2.87934343 |
100 | lysine catabolic process (GO:0006554) | 2.87934343 |
101 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.87808679 |
102 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.86991489 |
103 | purine-containing compound salvage (GO:0043101) | 2.84280015 |
104 | DNA topological change (GO:0006265) | 2.83989744 |
105 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.80636495 |
106 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.80180032 |
107 | glyoxylate metabolic process (GO:0046487) | 2.79738658 |
108 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.79606599 |
109 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.79606599 |
110 | mitotic sister chromatid segregation (GO:0000070) | 2.79229669 |
111 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.79192265 |
112 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.78463642 |
113 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.78377632 |
114 | short-chain fatty acid metabolic process (GO:0046459) | 2.77337881 |
115 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.77301365 |
116 | protein deneddylation (GO:0000338) | 2.74790868 |
117 | alpha-linolenic acid metabolic process (GO:0036109) | 2.74551568 |
118 | pore complex assembly (GO:0046931) | 2.74422335 |
119 | cysteine metabolic process (GO:0006534) | 2.74399700 |
120 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.74174468 |
121 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.73437844 |
122 | cell cycle G1/S phase transition (GO:0044843) | 2.73437844 |
123 | acyl-CoA biosynthetic process (GO:0071616) | 2.73282819 |
124 | thioester biosynthetic process (GO:0035384) | 2.73282819 |
125 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.73159282 |
126 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.73159282 |
127 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.73159282 |
128 | tyrosine metabolic process (GO:0006570) | 2.72758187 |
129 | alpha-amino acid catabolic process (GO:1901606) | 2.72591772 |
130 | regulation of beta-amyloid formation (GO:1902003) | 2.72436679 |
131 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.72351310 |
132 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.71954081 |
133 | amino acid import (GO:0043090) | 2.71713627 |
134 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.71124281 |
135 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.71124281 |
136 | peroxisome fission (GO:0016559) | 2.69712739 |
137 | cellular potassium ion homeostasis (GO:0030007) | 2.69532067 |
138 | positive regulation of ligase activity (GO:0051351) | 2.69035497 |
139 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.68497084 |
140 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.68497084 |
141 | L-glutamate transport (GO:0015813) | 2.68061476 |
142 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.67094293 |
143 | bile acid metabolic process (GO:0008206) | 2.67002968 |
144 | ketone body metabolic process (GO:1902224) | 2.66042092 |
145 | sister chromatid segregation (GO:0000819) | 2.65668132 |
146 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.65527842 |
147 | low-density lipoprotein particle remodeling (GO:0034374) | 2.65386202 |
148 | neuronal action potential propagation (GO:0019227) | 2.65372324 |
149 | homocysteine metabolic process (GO:0050667) | 2.65304141 |
150 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.65287002 |
151 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.64335969 |
152 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.64184379 |
153 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.64184379 |
154 | cellular amino acid catabolic process (GO:0009063) | 2.64099656 |
155 | indolalkylamine catabolic process (GO:0046218) | 2.63556929 |
156 | tryptophan catabolic process (GO:0006569) | 2.63556929 |
157 | indole-containing compound catabolic process (GO:0042436) | 2.63556929 |
158 | succinate metabolic process (GO:0006105) | 2.63083647 |
159 | DNA unwinding involved in DNA replication (GO:0006268) | 2.62600547 |
160 | aromatic amino acid family metabolic process (GO:0009072) | 2.61299103 |
161 | mitotic sister chromatid cohesion (GO:0007064) | 2.60925990 |
162 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.60073299 |
163 | cerebellar granule cell differentiation (GO:0021707) | 2.59034869 |
164 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.58626600 |
165 | regulation of ligase activity (GO:0051340) | 2.57298781 |
166 | transferrin transport (GO:0033572) | 2.54039783 |
167 | thioester metabolic process (GO:0035383) | 2.53555365 |
168 | acyl-CoA metabolic process (GO:0006637) | 2.53555365 |
169 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.53092574 |
170 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.51778749 |
171 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.51778749 |
172 | sulfur amino acid catabolic process (GO:0000098) | 2.51505361 |
173 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.51108793 |
174 | drug transmembrane transport (GO:0006855) | 2.50829854 |
175 | glutamine family amino acid catabolic process (GO:0009065) | 2.50534846 |
176 | tryptophan metabolic process (GO:0006568) | 2.49978558 |
177 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.49330342 |
178 | trivalent inorganic cation transport (GO:0072512) | 2.47305437 |
179 | ferric iron transport (GO:0015682) | 2.47305437 |
180 | long-term synaptic potentiation (GO:0060291) | 2.47283584 |
181 | reverse cholesterol transport (GO:0043691) | 2.46496546 |
182 | neurotransmitter secretion (GO:0007269) | 2.45964519 |
183 | regulation of lipoprotein metabolic process (GO:0050746) | 2.45221386 |
184 | glutathione biosynthetic process (GO:0006750) | 2.44691873 |
185 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.44652623 |
186 | cholesterol biosynthetic process (GO:0006695) | 2.43940732 |
187 | regulation of synaptic vesicle transport (GO:1902803) | 2.42944498 |
188 | regulation of bile acid biosynthetic process (GO:0070857) | 2.42691517 |
189 | glycerophospholipid catabolic process (GO:0046475) | 2.42536770 |
190 | high-density lipoprotein particle remodeling (GO:0034375) | 2.41685721 |
191 | synaptic vesicle maturation (GO:0016188) | 2.39727966 |
192 | negative regulation of protein localization to cell surface (GO:2000009) | 2.38929191 |
193 | vocalization behavior (GO:0071625) | 2.38889768 |
194 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.38604611 |
195 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.38529781 |
196 | regulation of cholesterol esterification (GO:0010872) | 2.38272826 |
197 | aldehyde catabolic process (GO:0046185) | 2.37465914 |
198 | cellular modified amino acid catabolic process (GO:0042219) | 2.37425719 |
199 | drug catabolic process (GO:0042737) | 2.36473740 |
200 | female mating behavior (GO:0060180) | 2.35989366 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.81210070 |
2 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.04658566 |
3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.04381153 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.96907912 |
5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.22650445 |
6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.09986905 |
7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.07151754 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.04715312 |
9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.91841697 |
10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.89448181 |
11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.85353966 |
12 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.82377162 |
13 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.75738551 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.63555552 |
15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.59784225 |
16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.57810571 |
17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.56110578 |
18 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.50665424 |
19 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.28280850 |
20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.25256360 |
21 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.22661190 |
22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.22427648 |
23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.22167651 |
24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.16709107 |
25 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12841161 |
26 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.12455091 |
27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.12379253 |
28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.08294818 |
29 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05417538 |
30 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.05382223 |
31 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04623579 |
32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.01989220 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.01750645 |
34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.01264990 |
35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00152121 |
36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.99912083 |
37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.99506560 |
38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.98093401 |
39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.97399010 |
40 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96072446 |
41 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.94726346 |
42 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.93667564 |
43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.92201180 |
44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.90896799 |
45 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90465208 |
46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.88899723 |
47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88615560 |
48 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86854139 |
49 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86526003 |
50 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.84195590 |
51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.83986572 |
52 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.83820182 |
53 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.82491565 |
54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.82320437 |
55 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81333354 |
56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77277195 |
57 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.76848554 |
58 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.76623936 |
59 | VDR_22108803_ChIP-Seq_LS180_Human | 1.75036082 |
60 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.74121289 |
61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72085090 |
62 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.70533467 |
63 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.70339733 |
64 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.70199079 |
65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.69305904 |
66 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.69035411 |
67 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.66475710 |
68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.64931764 |
69 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.63080202 |
70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.63080202 |
71 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62104075 |
72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61563045 |
73 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.60720712 |
74 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59131980 |
75 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56259770 |
76 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55571405 |
77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55571405 |
78 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.53988837 |
79 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.53088142 |
80 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.53088142 |
81 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.53088142 |
82 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49424279 |
83 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48724008 |
84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.48600544 |
85 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.47483921 |
86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.47145512 |
87 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46621975 |
88 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.46521700 |
89 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.45762724 |
90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.45377191 |
91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44668686 |
92 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.43852258 |
93 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.42239171 |
94 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.42126251 |
95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41593749 |
96 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.41143089 |
97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40086692 |
98 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.38537279 |
99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37197278 |
100 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.35874870 |
101 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34631982 |
102 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34460144 |
103 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33575250 |
104 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33512202 |
105 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.32645105 |
106 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31817921 |
107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.31810578 |
108 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30777377 |
109 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.29848528 |
110 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.29626650 |
111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28816122 |
112 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.27856738 |
113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27596303 |
114 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27331285 |
115 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25275819 |
116 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24367310 |
117 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.22070247 |
118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21477740 |
119 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20116851 |
120 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.18883536 |
121 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.18512495 |
122 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.18480579 |
123 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18422208 |
124 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18270035 |
125 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18082044 |
126 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.17995702 |
127 | EWS_26573619_Chip-Seq_HEK293_Human | 1.16871762 |
128 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16867444 |
129 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.16655468 |
130 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.16447738 |
131 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15397501 |
132 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14212411 |
133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11886187 |
134 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11870132 |
135 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.11497313 |
136 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11456867 |
137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11136853 |
138 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11009596 |
139 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10709632 |
140 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.10556498 |
141 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.10309765 |
142 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10235997 |
143 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08972966 |
144 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.08942083 |
145 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.08942083 |
146 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.08847821 |
147 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08743082 |
148 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.08506218 |
149 | MYB_26560356_Chip-Seq_TH2_Human | 1.07795410 |
150 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.07324020 |
151 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07242736 |
152 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06830406 |
153 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.06769662 |
154 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06049256 |
155 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04207996 |
156 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.04164154 |
157 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.04095548 |
158 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03606842 |
159 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.03231955 |
160 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03216178 |
161 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03156126 |
162 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.02879664 |
163 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02282814 |
164 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01981629 |
165 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.00765043 |
166 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00743110 |
167 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00674064 |
168 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.00534272 |
169 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00486732 |
170 | JUN_21703547_ChIP-Seq_K562_Human | 1.00384608 |
171 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00337450 |
172 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00336133 |
173 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99826682 |
174 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99594501 |
175 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99445281 |
176 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.99050259 |
177 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.98722686 |
178 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.98492953 |
179 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.98045467 |
180 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95996196 |
181 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.95024149 |
182 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94400432 |
183 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.92603196 |
184 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91407195 |
185 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90393331 |
186 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.89787957 |
187 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87323728 |
188 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.86310491 |
189 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.84317528 |
190 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.84315606 |
191 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.83318716 |
192 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83075486 |
193 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.82984512 |
194 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81163308 |
195 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80918678 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.06896934 |
2 | MP0010094_abnormal_chromosome_stability | 3.98674373 |
3 | MP0005360_urolithiasis | 3.80928430 |
4 | MP0004957_abnormal_blastocyst_morpholog | 3.68048864 |
5 | MP0003880_abnormal_central_pattern | 3.61468895 |
6 | MP0003693_abnormal_embryo_hatching | 3.54272935 |
7 | MP0008058_abnormal_DNA_repair | 3.41191844 |
8 | MP0008057_abnormal_DNA_replication | 3.33148843 |
9 | MP0003195_calcinosis | 3.26744974 |
10 | MP0003111_abnormal_nucleus_morphology | 3.14326570 |
11 | MP0005085_abnormal_gallbladder_physiolo | 2.95466571 |
12 | MP0003077_abnormal_cell_cycle | 2.89259308 |
13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.78149587 |
14 | MP0008007_abnormal_cellular_replicative | 2.69130206 |
15 | MP0005464_abnormal_platelet_physiology | 2.63140065 |
16 | MP0003690_abnormal_glial_cell | 2.60550652 |
17 | MP0003806_abnormal_nucleotide_metabolis | 2.58225216 |
18 | MP0005646_abnormal_pituitary_gland | 2.56501507 |
19 | MP0005365_abnormal_bile_salt | 2.51219539 |
20 | MP0004043_abnormal_pH_regulation | 2.47355020 |
21 | MP0008932_abnormal_embryonic_tissue | 2.41102037 |
22 | MP0002064_seizures | 2.38916885 |
23 | MP0004859_abnormal_synaptic_plasticity | 2.29888363 |
24 | MP0004270_analgesia | 2.29039671 |
25 | MP0009046_muscle_twitch | 2.28824648 |
26 | MP0003329_amyloid_beta_deposits | 2.28779730 |
27 | MP0003635_abnormal_synaptic_transmissio | 2.14708358 |
28 | MP0002272_abnormal_nervous_system | 2.12362166 |
29 | MP0005332_abnormal_amino_acid | 2.11062338 |
30 | MP0009745_abnormal_behavioral_response | 2.10437185 |
31 | MP0000920_abnormal_myelination | 2.08131236 |
32 | MP0001486_abnormal_startle_reflex | 2.01233993 |
33 | MP0001835_abnormal_antigen_presentation | 1.99882847 |
34 | MP0002736_abnormal_nociception_after | 1.99536544 |
35 | MP0002009_preneoplasia | 1.87720795 |
36 | MP0001968_abnormal_touch/_nociception | 1.87714119 |
37 | MP0003941_abnormal_skin_development | 1.84366245 |
38 | MP0002148_abnormal_hypersensitivity_rea | 1.83722206 |
39 | MP0002063_abnormal_learning/memory/cond | 1.82294507 |
40 | MP0002572_abnormal_emotion/affect_behav | 1.78064648 |
41 | MP0009785_altered_susceptibility_to | 1.76899280 |
42 | MP0010307_abnormal_tumor_latency | 1.75905204 |
43 | MP0002734_abnormal_mechanical_nocicepti | 1.75384964 |
44 | MP0009333_abnormal_splenocyte_physiolog | 1.74798429 |
45 | MP0002396_abnormal_hematopoietic_system | 1.74556677 |
46 | MP0001853_heart_inflammation | 1.74318873 |
47 | MP0001529_abnormal_vocalization | 1.72954071 |
48 | MP0005671_abnormal_response_to | 1.70738662 |
49 | MP0001984_abnormal_olfaction | 1.70041669 |
50 | MP0002006_tumorigenesis | 1.68932320 |
51 | MP0003718_maternal_effect | 1.66797802 |
52 | MP0004142_abnormal_muscle_tone | 1.66700323 |
53 | MP0000604_amyloidosis | 1.65127067 |
54 | MP0006082_CNS_inflammation | 1.63210248 |
55 | MP0003724_increased_susceptibility_to | 1.61436996 |
56 | MP0003252_abnormal_bile_duct | 1.60878289 |
57 | MP0009780_abnormal_chondrocyte_physiolo | 1.60424400 |
58 | MP0003448_altered_tumor_morphology | 1.59136177 |
59 | MP0000350_abnormal_cell_proliferation | 1.57518605 |
60 | MP0002876_abnormal_thyroid_physiology | 1.53405634 |
61 | MP0010329_abnormal_lipoprotein_level | 1.49989424 |
62 | MP0001730_embryonic_growth_arrest | 1.49617643 |
63 | MP0001440_abnormal_grooming_behavior | 1.49215958 |
64 | MP0003633_abnormal_nervous_system | 1.48993239 |
65 | MP0004885_abnormal_endolymph | 1.48629678 |
66 | MP0002067_abnormal_sensory_capabilities | 1.47375125 |
67 | MP0002166_altered_tumor_susceptibility | 1.47209899 |
68 | MP0006054_spinal_hemorrhage | 1.46190502 |
69 | MP0003303_peritoneal_inflammation | 1.45890706 |
70 | MP0005551_abnormal_eye_electrophysiolog | 1.42541346 |
71 | MP0002398_abnormal_bone_marrow | 1.40507006 |
72 | MP0001501_abnormal_sleep_pattern | 1.38029053 |
73 | MP0002877_abnormal_melanocyte_morpholog | 1.37837964 |
74 | MP0002452_abnormal_antigen_presenting | 1.36442034 |
75 | MP0003786_premature_aging | 1.35075626 |
76 | MP0005000_abnormal_immune_tolerance | 1.32086280 |
77 | MP0008877_abnormal_DNA_methylation | 1.31958764 |
78 | MP0003631_nervous_system_phenotype | 1.31627054 |
79 | MP0000343_altered_response_to | 1.31625573 |
80 | MP0002229_neurodegeneration | 1.31576352 |
81 | MP0008004_abnormal_stomach_pH | 1.30690744 |
82 | MP0000689_abnormal_spleen_morphology | 1.29965504 |
83 | MP0002735_abnormal_chemical_nociception | 1.29776586 |
84 | MP0002822_catalepsy | 1.29254579 |
85 | MP0003634_abnormal_glial_cell | 1.29158057 |
86 | MP0002132_abnormal_respiratory_system | 1.29060183 |
87 | MP0002019_abnormal_tumor_incidence | 1.29048151 |
88 | MP0009840_abnormal_foam_cell | 1.28908205 |
89 | MP0004808_abnormal_hematopoietic_stem | 1.28204089 |
90 | MP0001800_abnormal_humoral_immune | 1.27426956 |
91 | MP0000313_abnormal_cell_death | 1.27233007 |
92 | MP0002419_abnormal_innate_immunity | 1.26253651 |
93 | MP0010352_gastrointestinal_tract_polyps | 1.25772203 |
94 | MP0001905_abnormal_dopamine_level | 1.25578296 |
95 | MP0001970_abnormal_pain_threshold | 1.24798794 |
96 | MP0000858_altered_metastatic_potential | 1.24358740 |
97 | MP0002723_abnormal_immune_serum | 1.23510394 |
98 | MP0002722_abnormal_immune_system | 1.22015892 |
99 | MP0002090_abnormal_vision | 1.21859655 |
100 | MP0002420_abnormal_adaptive_immunity | 1.20437768 |
101 | MP0002118_abnormal_lipid_homeostasis | 1.19860836 |
102 | MP0001819_abnormal_immune_cell | 1.19512845 |
103 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19245553 |
104 | MP0003632_abnormal_nervous_system | 1.18986309 |
105 | MP0006035_abnormal_mitochondrial_morpho | 1.18792180 |
106 | MP0001697_abnormal_embryo_size | 1.18240438 |
107 | MP0003191_abnormal_cellular_cholesterol | 1.15676583 |
108 | MP0002733_abnormal_thermal_nociception | 1.15615756 |
109 | MP0005171_absent_coat_pigmentation | 1.15594729 |
110 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.15213237 |
111 | MP0005025_abnormal_response_to | 1.14600727 |
112 | MP0004742_abnormal_vestibular_system | 1.14565493 |
113 | MP0000358_abnormal_cell_content/ | 1.13980626 |
114 | MP0004019_abnormal_vitamin_homeostasis | 1.13967234 |
115 | MP0005083_abnormal_biliary_tract | 1.12909178 |
116 | MP0003656_abnormal_erythrocyte_physiolo | 1.11688936 |
117 | MP0004924_abnormal_behavior | 1.09737330 |
118 | MP0005386_behavior/neurological_phenoty | 1.09737330 |
119 | MP0003950_abnormal_plasma_membrane | 1.09715430 |
120 | MP0005423_abnormal_somatic_nervous | 1.09345180 |
121 | MP0004147_increased_porphyrin_level | 1.09068804 |
122 | MP0002405_respiratory_system_inflammati | 1.08096769 |
123 | MP0002429_abnormal_blood_cell | 1.07984749 |
124 | MP0009697_abnormal_copulation | 1.07942520 |
125 | MP0006276_abnormal_autonomic_nervous | 1.07047535 |
126 | MP0001177_atelectasis | 1.06960206 |
127 | MP0003186_abnormal_redox_activity | 1.06444896 |
128 | MP0009763_increased_sensitivity_to | 1.06267430 |
129 | MP0001764_abnormal_homeostasis | 1.05792553 |
130 | MP0004947_skin_inflammation | 1.05710778 |
131 | MP0000716_abnormal_immune_system | 1.04229624 |
132 | MP0005397_hematopoietic_system_phenotyp | 1.03622810 |
133 | MP0001545_abnormal_hematopoietic_system | 1.03622810 |
134 | MP0005501_abnormal_skin_physiology | 1.03343000 |
135 | MP0005535_abnormal_body_temperature | 1.02731224 |
136 | MP0001485_abnormal_pinna_reflex | 1.02439570 |
137 | MP0000490_abnormal_crypts_of | 1.02345973 |
138 | MP0000013_abnormal_adipose_tissue | 1.02160843 |
139 | MP0001672_abnormal_embryogenesis/_devel | 1.02063527 |
140 | MP0005380_embryogenesis_phenotype | 1.02063527 |
141 | MP0000566_synostosis | 1.01836007 |
142 | MP0003183_abnormal_peptide_metabolism | 1.00955570 |
143 | MP0001963_abnormal_hearing_physiology | 1.00930964 |
144 | MP0000465_gastrointestinal_hemorrhage | 1.00647173 |
145 | MP0009765_abnormal_xenobiotic_induced | 1.00415679 |
146 | MP0003890_abnormal_embryonic-extraembry | 1.00210557 |
147 | MP0001666_abnormal_nutrient_absorption | 0.99874263 |
148 | MP0001845_abnormal_inflammatory_respons | 0.99208733 |
149 | MP0002796_impaired_skin_barrier | 0.99035025 |
150 | MP0002066_abnormal_motor_capabilities/c | 0.98648626 |
151 | MP0002080_prenatal_lethality | 0.97460019 |
152 | MP0001502_abnormal_circadian_rhythm | 0.96722331 |
153 | MP0009764_decreased_sensitivity_to | 0.96513114 |
154 | MP0005645_abnormal_hypothalamus_physiol | 0.95988644 |
155 | MP0000703_abnormal_thymus_morphology | 0.95944087 |
156 | MP0010155_abnormal_intestine_physiology | 0.95270915 |
157 | MP0003075_altered_response_to | 0.94847167 |
158 | MP0001986_abnormal_taste_sensitivity | 0.94741749 |
159 | MP0008569_lethality_at_weaning | 0.93247641 |
160 | MP0005058_abnormal_lysosome_morphology | 0.92298930 |
161 | MP0001790_abnormal_immune_system | 0.90669042 |
162 | MP0005387_immune_system_phenotype | 0.90669042 |
163 | MP0003984_embryonic_growth_retardation | 0.90618080 |
164 | MP0002557_abnormal_social/conspecific_i | 0.90324866 |
165 | MP0003453_abnormal_keratinocyte_physiol | 0.88367732 |
166 | MP0001929_abnormal_gametogenesis | 0.88003840 |
167 | MP0003879_abnormal_hair_cell | 0.87717846 |
168 | MP0002882_abnormal_neuron_morphology | 0.87646905 |
169 | MP0001191_abnormal_skin_condition | 0.87182842 |
170 | MP0003868_abnormal_feces_composition | 0.86648957 |
171 | MP0005084_abnormal_gallbladder_morpholo | 0.86590797 |
172 | MP0002088_abnormal_embryonic_growth/wei | 0.85360866 |
173 | MP0000778_abnormal_nervous_system | 0.84711160 |
174 | MP0001293_anophthalmia | 0.83668541 |
175 | MP0002210_abnormal_sex_determination | 0.83013986 |
176 | MP0002086_abnormal_extraembryonic_tissu | 0.82514708 |
177 | MP0005384_cellular_phenotype | 0.81455256 |
178 | MP0005621_abnormal_cell_physiology | 0.80318048 |
179 | MP0003011_delayed_dark_adaptation | 0.79848328 |
180 | MP0003763_abnormal_thymus_physiology | 0.79323816 |
181 | MP0002837_dystrophic_cardiac_calcinosis | 0.78673039 |
182 | MP0000639_abnormal_adrenal_gland | 0.77221677 |
183 | MP0001145_abnormal_male_reproductive | 0.75433102 |
184 | MP0008260_abnormal_autophagy | 0.75215612 |
185 | MP0005408_hypopigmentation | 0.75162657 |
186 | MP0000955_abnormal_spinal_cord | 0.75075023 |
187 | MP0008872_abnormal_physiological_respon | 0.73586984 |
188 | MP0006036_abnormal_mitochondrial_physio | 0.72916375 |
189 | MP0010386_abnormal_urinary_bladder | 0.72787318 |
190 | MP0000230_abnormal_systemic_arterial | 0.71233065 |
191 | MP0004858_abnormal_nervous_system | 0.68376920 |
192 | MP0003136_yellow_coat_color | 0.68055298 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.26236340 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.22631269 |
3 | Focal motor seizures (HP:0011153) | 3.84450436 |
4 | Chromsome breakage (HP:0040012) | 3.81931855 |
5 | Intrahepatic cholestasis (HP:0001406) | 3.67465818 |
6 | Abnormality of chromosome stability (HP:0003220) | 3.40498297 |
7 | Pheochromocytoma (HP:0002666) | 3.38573881 |
8 | Hyperventilation (HP:0002883) | 3.35153585 |
9 | Neurofibrillary tangles (HP:0002185) | 3.30371930 |
10 | Atonic seizures (HP:0010819) | 3.11416275 |
11 | Autoimmune hemolytic anemia (HP:0001890) | 3.09520805 |
12 | Petechiae (HP:0000967) | 3.08399910 |
13 | Abnormal lung lobation (HP:0002101) | 3.06709108 |
14 | Xanthomatosis (HP:0000991) | 3.05110838 |
15 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.99048152 |
16 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.99048152 |
17 | Neuroendocrine neoplasm (HP:0100634) | 2.98662669 |
18 | Myokymia (HP:0002411) | 2.97113818 |
19 | Abnormality of the preputium (HP:0100587) | 2.93138340 |
20 | Short middle phalanx of the 5th finger (HP:0004220) | 2.91146683 |
21 | Meckel diverticulum (HP:0002245) | 2.90231989 |
22 | Increased IgM level (HP:0003496) | 2.80135851 |
23 | Nausea (HP:0002018) | 2.79224373 |
24 | Epileptic encephalopathy (HP:0200134) | 2.78735001 |
25 | Sensorimotor neuropathy (HP:0007141) | 2.74095898 |
26 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.71879530 |
27 | Abnormality of glycolysis (HP:0004366) | 2.70240344 |
28 | Increased serum pyruvate (HP:0003542) | 2.70240344 |
29 | Abnormal gallbladder physiology (HP:0012438) | 2.70117517 |
30 | Cholecystitis (HP:0001082) | 2.70117517 |
31 | Hyperlipoproteinemia (HP:0010980) | 2.70078882 |
32 | Small intestinal stenosis (HP:0012848) | 2.67705762 |
33 | Duodenal stenosis (HP:0100867) | 2.67705762 |
34 | Rhabdomyosarcoma (HP:0002859) | 2.65744104 |
35 | Abnormality of methionine metabolism (HP:0010901) | 2.64267796 |
36 | Embryonal renal neoplasm (HP:0011794) | 2.63835735 |
37 | Acute encephalopathy (HP:0006846) | 2.63596108 |
38 | Hyperglycinemia (HP:0002154) | 2.63421904 |
39 | Insidious onset (HP:0003587) | 2.63183479 |
40 | Termporal pattern (HP:0011008) | 2.63183479 |
41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.62916690 |
42 | Abnormality of glycine metabolism (HP:0010895) | 2.62916690 |
43 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62413868 |
44 | Abnormality of the ileum (HP:0001549) | 2.62048223 |
45 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.61857358 |
46 | Hypobetalipoproteinemia (HP:0003563) | 2.61392493 |
47 | Aplastic anemia (HP:0001915) | 2.61099467 |
48 | Myelodysplasia (HP:0002863) | 2.60742373 |
49 | Gout (HP:0001997) | 2.59462894 |
50 | Increased circulating renin level (HP:0000848) | 2.57348682 |
51 | Dyschromatopsia (HP:0007641) | 2.56833046 |
52 | Complement deficiency (HP:0004431) | 2.56570277 |
53 | Metabolic alkalosis (HP:0200114) | 2.52372710 |
54 | B lymphocytopenia (HP:0010976) | 2.52235759 |
55 | Prolonged partial thromboplastin time (HP:0003645) | 2.51986162 |
56 | Multiple enchondromatosis (HP:0005701) | 2.50628883 |
57 | Hypokalemic alkalosis (HP:0001949) | 2.50247249 |
58 | Deep venous thrombosis (HP:0002625) | 2.49785105 |
59 | Increased mean platelet volume (HP:0011877) | 2.49193367 |
60 | Abnormality of the corticospinal tract (HP:0002492) | 2.48303212 |
61 | Scanning speech (HP:0002168) | 2.47057074 |
62 | Absence seizures (HP:0002121) | 2.40932158 |
63 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.38972469 |
64 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.38972469 |
65 | Single umbilical artery (HP:0001195) | 2.38972469 |
66 | Cerebral inclusion bodies (HP:0100314) | 2.38221629 |
67 | Medulloblastoma (HP:0002885) | 2.37893436 |
68 | Abnormality of the prostate (HP:0008775) | 2.37622545 |
69 | Cerebral edema (HP:0002181) | 2.35593469 |
70 | Generalized tonic-clonic seizures (HP:0002069) | 2.35499653 |
71 | Focal seizures (HP:0007359) | 2.33563288 |
72 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.33331386 |
73 | Acute necrotizing encephalopathy (HP:0006965) | 2.33100699 |
74 | Abnormal platelet volume (HP:0011876) | 2.32620865 |
75 | Ovarian neoplasm (HP:0100615) | 2.32027381 |
76 | Ketosis (HP:0001946) | 2.32020083 |
77 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31457694 |
78 | Dialeptic seizures (HP:0011146) | 2.30854451 |
79 | Action tremor (HP:0002345) | 2.30291305 |
80 | Agnosia (HP:0010524) | 2.29753223 |
81 | Fat malabsorption (HP:0002630) | 2.28941489 |
82 | Prolonged bleeding time (HP:0003010) | 2.28476445 |
83 | Hyperammonemia (HP:0001987) | 2.27901096 |
84 | Cerebral hemorrhage (HP:0001342) | 2.26759713 |
85 | Hepatosplenomegaly (HP:0001433) | 2.26583595 |
86 | Abnormality of B cell number (HP:0010975) | 2.26017082 |
87 | Paralysis (HP:0003470) | 2.25256657 |
88 | Biliary tract neoplasm (HP:0100574) | 2.24563369 |
89 | Oral leukoplakia (HP:0002745) | 2.24395626 |
90 | Conjugated hyperbilirubinemia (HP:0002908) | 2.23748773 |
91 | Febrile seizures (HP:0002373) | 2.22669593 |
92 | Abnormality of alanine metabolism (HP:0010916) | 2.22655879 |
93 | Hyperalaninemia (HP:0003348) | 2.22655879 |
94 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.22655879 |
95 | Increased hepatocellular lipid droplets (HP:0006565) | 2.22436582 |
96 | Colon cancer (HP:0003003) | 2.22392321 |
97 | Neoplasm of the colon (HP:0100273) | 2.21455668 |
98 | Clubbing of toes (HP:0100760) | 2.21424760 |
99 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.19479606 |
100 | Papillary thyroid carcinoma (HP:0002895) | 2.19341348 |
101 | Leukodystrophy (HP:0002415) | 2.18692108 |
102 | Progressive macrocephaly (HP:0004481) | 2.17629561 |
103 | Abnormality of the anterior horn cell (HP:0006802) | 2.17330149 |
104 | Degeneration of anterior horn cells (HP:0002398) | 2.17330149 |
105 | Renal Fanconi syndrome (HP:0001994) | 2.15208118 |
106 | Pancytopenia (HP:0001876) | 2.14933207 |
107 | Blue irides (HP:0000635) | 2.14357600 |
108 | Alkalosis (HP:0001948) | 2.14064155 |
109 | Split foot (HP:0001839) | 2.13829866 |
110 | Birth length less than 3rd percentile (HP:0003561) | 2.13542157 |
111 | Dysmetria (HP:0001310) | 2.12175206 |
112 | IgM deficiency (HP:0002850) | 2.12038677 |
113 | Lethargy (HP:0001254) | 2.11783705 |
114 | Dysdiadochokinesis (HP:0002075) | 2.11660193 |
115 | Hypomagnesemia (HP:0002917) | 2.11442946 |
116 | Type I transferrin isoform profile (HP:0003642) | 2.10852019 |
117 | Progressive external ophthalmoplegia (HP:0000590) | 2.10811302 |
118 | Ketoacidosis (HP:0001993) | 2.10044377 |
119 | Abnormal eating behavior (HP:0100738) | 2.09528830 |
120 | Hyperglycinuria (HP:0003108) | 2.06854383 |
121 | Intention tremor (HP:0002080) | 2.06796922 |
122 | Carpal bone hypoplasia (HP:0001498) | 2.06500928 |
123 | Recurrent abscess formation (HP:0002722) | 2.06053632 |
124 | Reticulocytopenia (HP:0001896) | 2.05397097 |
125 | Recurrent bacterial skin infections (HP:0005406) | 2.05284062 |
126 | Abnormal gallbladder morphology (HP:0012437) | 2.04272718 |
127 | Abnormality of the duodenum (HP:0002246) | 2.03503634 |
128 | Purpura (HP:0000979) | 2.03501330 |
129 | Amaurosis fugax (HP:0100576) | 2.02274445 |
130 | Methylmalonic acidemia (HP:0002912) | 2.01398275 |
131 | Prostate neoplasm (HP:0100787) | 2.00093078 |
132 | Vacuolated lymphocytes (HP:0001922) | 1.99505920 |
133 | Mediastinal lymphadenopathy (HP:0100721) | 1.99417714 |
134 | Gonadal dysgenesis (HP:0000133) | 1.99388269 |
135 | Neoplasm of the small intestine (HP:0100833) | 1.98563236 |
136 | Aplasia involving bones of the extremities (HP:0009825) | 1.97943618 |
137 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97943618 |
138 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97943618 |
139 | Abnormality of macrophages (HP:0004311) | 1.97487141 |
140 | Steatorrhea (HP:0002570) | 1.97430487 |
141 | Generalized myoclonic seizures (HP:0002123) | 1.97417148 |
142 | Epileptiform EEG discharges (HP:0011182) | 1.96853034 |
143 | Lymphoma (HP:0002665) | 1.96543437 |
144 | Recurrent viral infections (HP:0004429) | 1.96277573 |
145 | Status epilepticus (HP:0002133) | 1.96139828 |
146 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.95829555 |
147 | Reduced antithrombin III activity (HP:0001976) | 1.94080936 |
148 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93388276 |
149 | Spastic paraparesis (HP:0002313) | 1.92858853 |
150 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.92801077 |
151 | Systemic lupus erythematosus (HP:0002725) | 1.92726673 |
152 | Progressive cerebellar ataxia (HP:0002073) | 1.92551880 |
153 | Neoplasm of the rectum (HP:0100743) | 1.92025881 |
154 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.91803316 |
155 | Volvulus (HP:0002580) | 1.91170820 |
156 | Abnormality of serum amino acid levels (HP:0003112) | 1.90550370 |
157 | Abnormality of the umbilical cord (HP:0010881) | 1.90031348 |
158 | EEG with generalized epileptiform discharges (HP:0011198) | 1.88349332 |
159 | Combined immunodeficiency (HP:0005387) | 1.88277191 |
160 | Epidermoid cyst (HP:0200040) | 1.87895799 |
161 | Autoimmune thrombocytopenia (HP:0001973) | 1.87314940 |
162 | Hypolipoproteinemia (HP:0010981) | 1.86972583 |
163 | Thyroid carcinoma (HP:0002890) | 1.86647672 |
164 | Irritability (HP:0000737) | 1.86091218 |
165 | Autoamputation (HP:0001218) | 1.85560343 |
166 | Conjunctival telangiectasia (HP:0000524) | 1.85379879 |
167 | Gait imbalance (HP:0002141) | 1.84865315 |
168 | Abnormal hair whorl (HP:0010721) | 1.84848654 |
169 | Stomatitis (HP:0010280) | 1.84651027 |
170 | Abnormal auditory evoked potentials (HP:0006958) | 1.84613193 |
171 | Sloping forehead (HP:0000340) | 1.84534312 |
172 | Anxiety (HP:0000739) | 1.83059701 |
173 | Peripheral hypomyelination (HP:0007182) | 1.82618548 |
174 | Bone marrow hypocellularity (HP:0005528) | 1.82422057 |
175 | Epiphyseal stippling (HP:0010655) | 1.82394039 |
176 | Uterine neoplasm (HP:0010784) | 1.81182213 |
177 | Fair hair (HP:0002286) | 1.80802627 |
178 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.80771262 |
179 | Mitochondrial inheritance (HP:0001427) | 1.80440217 |
180 | Spastic gait (HP:0002064) | 1.80348901 |
181 | Medial flaring of the eyebrow (HP:0010747) | 1.80190628 |
182 | Ascites (HP:0001541) | 1.79937304 |
183 | Neoplasm of the pancreas (HP:0002894) | 1.79441651 |
184 | Paraparesis (HP:0002385) | 1.79377554 |
185 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.78216246 |
186 | Thrombocytosis (HP:0001894) | 1.77974167 |
187 | Exertional dyspnea (HP:0002875) | 1.77967256 |
188 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.77010727 |
189 | Lipid accumulation in hepatocytes (HP:0006561) | 1.76503964 |
190 | Respiratory difficulties (HP:0002880) | 1.71837654 |
191 | Median cleft lip (HP:0000161) | 1.71445888 |
192 | Abnormal protein glycosylation (HP:0012346) | 1.69503717 |
193 | Abnormal glycosylation (HP:0012345) | 1.69503717 |
194 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.69503717 |
195 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.69503717 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CASK | 4.59326649 |
2 | OXSR1 | 3.76976332 |
3 | BUB1 | 3.70472947 |
4 | STK39 | 3.07554463 |
5 | EIF2AK3 | 2.94096740 |
6 | CDC7 | 2.84268424 |
7 | TTK | 2.78607492 |
8 | SRPK1 | 2.71532206 |
9 | EIF2AK1 | 2.59843068 |
10 | PLK4 | 2.45787349 |
11 | MKNK1 | 2.34144510 |
12 | BRSK2 | 2.23210677 |
13 | TRIM28 | 2.17342294 |
14 | MAP2K7 | 2.15836198 |
15 | ACVR1B | 2.15169984 |
16 | SGK223 | 2.13752201 |
17 | SGK494 | 2.13752201 |
18 | EPHA4 | 2.13355002 |
19 | VRK2 | 2.09810933 |
20 | PLK3 | 2.08012631 |
21 | MAP3K4 | 2.04511627 |
22 | WEE1 | 2.01200678 |
23 | WNK4 | 1.97259234 |
24 | NEK1 | 1.96314903 |
25 | PRPF4B | 1.96043108 |
26 | NTRK3 | 1.91356360 |
27 | MKNK2 | 1.88123169 |
28 | ZAK | 1.87024067 |
29 | ERBB4 | 1.83423243 |
30 | VRK1 | 1.82715163 |
31 | NUAK1 | 1.81582013 |
32 | MAP3K12 | 1.81308407 |
33 | PLK2 | 1.80463417 |
34 | MAPKAPK5 | 1.77274409 |
35 | WNK3 | 1.73432490 |
36 | CDK19 | 1.73190266 |
37 | AKT3 | 1.70998531 |
38 | PBK | 1.66858923 |
39 | MAP2K4 | 1.64038337 |
40 | ARAF | 1.58099141 |
41 | NME2 | 1.55784306 |
42 | BMPR1B | 1.54481833 |
43 | PDK2 | 1.52373205 |
44 | STK24 | 1.47348971 |
45 | BCR | 1.44672968 |
46 | NTRK1 | 1.43012856 |
47 | PDK3 | 1.41409900 |
48 | PDK4 | 1.41409900 |
49 | FGFR2 | 1.40594575 |
50 | CAMK2B | 1.37630886 |
51 | BCKDK | 1.31626532 |
52 | SCYL2 | 1.28933104 |
53 | PLK1 | 1.27218898 |
54 | GRK5 | 1.26397633 |
55 | DAPK2 | 1.23553685 |
56 | MINK1 | 1.21965627 |
57 | TAF1 | 1.21468964 |
58 | IRAK2 | 1.20919636 |
59 | SGK2 | 1.20725779 |
60 | INSRR | 1.20574394 |
61 | PKN1 | 1.18684308 |
62 | MAP3K9 | 1.17689042 |
63 | TEC | 1.15598724 |
64 | WNK1 | 1.14567010 |
65 | CAMK2A | 1.13180218 |
66 | CAMK2G | 1.12950544 |
67 | CAMK2D | 1.12863821 |
68 | STK3 | 1.11622535 |
69 | EPHB1 | 1.10509086 |
70 | MST4 | 1.10507713 |
71 | PINK1 | 1.08518590 |
72 | CDK6 | 1.08076093 |
73 | BMPR2 | 1.07528226 |
74 | PRKCG | 1.06872437 |
75 | MET | 1.06507403 |
76 | RPS6KA4 | 1.05110009 |
77 | MAPK15 | 1.04256229 |
78 | ATR | 1.03660975 |
79 | IRAK1 | 1.03622365 |
80 | PRKCE | 1.03566249 |
81 | STK10 | 1.03466962 |
82 | PAK6 | 1.02957153 |
83 | ERBB3 | 0.98268935 |
84 | LIMK1 | 0.97350173 |
85 | RIPK4 | 0.97004327 |
86 | CDK5 | 0.93244621 |
87 | EIF2AK2 | 0.92028926 |
88 | TESK2 | 0.91090390 |
89 | AURKB | 0.90935388 |
90 | STK16 | 0.90932661 |
91 | DYRK3 | 0.89327104 |
92 | MAP3K14 | 0.88956443 |
93 | NTRK2 | 0.85854833 |
94 | FRK | 0.85058027 |
95 | CSNK1G2 | 0.84835327 |
96 | KSR2 | 0.81359139 |
97 | PAK3 | 0.80648094 |
98 | SIK3 | 0.80481754 |
99 | CSNK1G3 | 0.80074457 |
100 | NEK6 | 0.79887835 |
101 | ADRBK2 | 0.79835406 |
102 | CHEK2 | 0.79739570 |
103 | GRK7 | 0.79660937 |
104 | BRAF | 0.79304522 |
105 | MATK | 0.78673132 |
106 | BRSK1 | 0.78254630 |
107 | NEK9 | 0.77880431 |
108 | TGFBR1 | 0.77811928 |
109 | IRAK3 | 0.75777689 |
110 | KDR | 0.75641098 |
111 | STK4 | 0.75357603 |
112 | PDPK1 | 0.69914654 |
113 | TNIK | 0.69836206 |
114 | CAMKK2 | 0.68821428 |
115 | PAK4 | 0.68088438 |
116 | SGK3 | 0.68013737 |
117 | CSF1R | 0.67630812 |
118 | CDK7 | 0.66866059 |
119 | IKBKB | 0.66098950 |
120 | MAP3K13 | 0.65108623 |
121 | BTK | 0.64954229 |
122 | TAOK2 | 0.64881953 |
123 | FLT3 | 0.64318524 |
124 | PHKG2 | 0.64028698 |
125 | PHKG1 | 0.64028698 |
126 | MAP3K8 | 0.63815837 |
127 | PASK | 0.63709853 |
128 | UHMK1 | 0.62197033 |
129 | MAP3K2 | 0.61489464 |
130 | ALK | 0.59656091 |
131 | TYK2 | 0.59408651 |
132 | CLK1 | 0.59364609 |
133 | ATM | 0.58816449 |
134 | CDK14 | 0.57572254 |
135 | CHEK1 | 0.57028681 |
136 | BMX | 0.56910609 |
137 | MARK1 | 0.56272526 |
138 | MAPK13 | 0.54887488 |
139 | MAPK12 | 0.54759724 |
140 | CSNK1A1L | 0.53933877 |
141 | CDK4 | 0.53761045 |
142 | PDK1 | 0.53313534 |
143 | NLK | 0.53302241 |
144 | MAPK7 | 0.53039129 |
145 | IRAK4 | 0.52474164 |
146 | FGR | 0.52433687 |
147 | CDK18 | 0.52323463 |
148 | LYN | 0.52208357 |
149 | CDK9 | 0.51825247 |
150 | CSNK2A1 | 0.50226363 |
151 | NME1 | 0.49849858 |
152 | PRKD3 | 0.49746848 |
153 | CDK15 | 0.49501828 |
154 | PRKCH | 0.49396441 |
155 | PRKCQ | 0.49227902 |
156 | ROCK2 | 0.48921993 |
157 | PIM1 | 0.48190865 |
158 | CCNB1 | 0.47834699 |
159 | TAOK3 | 0.47758995 |
160 | MAP3K5 | 0.46716376 |
161 | TSSK6 | 0.46590379 |
162 | SGK1 | 0.46494186 |
163 | RPS6KB2 | 0.45780032 |
164 | AURKA | 0.45338908 |
165 | PRKACA | 0.45265958 |
166 | BLK | 0.44182117 |
167 | CSNK1G1 | 0.43564375 |
168 | CDK8 | 0.41683920 |
169 | YES1 | 0.41471535 |
170 | DYRK1A | 0.41158289 |
171 | PRKCA | 0.41121587 |
172 | NEK2 | 0.40887968 |
173 | PAK1 | 0.40616126 |
174 | SYK | 0.40604075 |
175 | PIK3CA | 0.39695645 |
176 | CSNK2A2 | 0.39614847 |
177 | MARK3 | 0.39314950 |
178 | ILK | 0.38367119 |
179 | DAPK1 | 0.37866839 |
180 | PRKACB | 0.36657772 |
181 | IKBKE | 0.36081563 |
182 | STK38L | 0.36081439 |
183 | TBK1 | 0.34199725 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.27266196 |
2 | Mismatch repair_Homo sapiens_hsa03430 | 4.01313425 |
3 | DNA replication_Homo sapiens_hsa03030 | 3.85074789 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.67225130 |
5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.93743917 |
6 | * Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.64854925 |
7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.62911920 |
8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.56329246 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.54957908 |
10 | Homologous recombination_Homo sapiens_hsa03440 | 2.47093614 |
11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.45085953 |
12 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.41113136 |
13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37857769 |
14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.28868251 |
15 | Cell cycle_Homo sapiens_hsa04110 | 2.25529782 |
16 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.12676707 |
17 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04911246 |
18 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03598595 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.02513328 |
20 | Spliceosome_Homo sapiens_hsa03040 | 2.01296377 |
21 | Base excision repair_Homo sapiens_hsa03410 | 2.01024997 |
22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.99741802 |
23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.92102183 |
24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.90240777 |
25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.83102307 |
26 | * RNA transport_Homo sapiens_hsa03013 | 1.81388234 |
27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.78788617 |
28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77787666 |
29 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.76500229 |
30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.75876568 |
31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.74772553 |
32 | Legionellosis_Homo sapiens_hsa05134 | 1.73887218 |
33 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72285376 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.72174245 |
35 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.71643558 |
36 | RNA polymerase_Homo sapiens_hsa03020 | 1.71442915 |
37 | Ribosome_Homo sapiens_hsa03010 | 1.69413386 |
38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.66520900 |
39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66217299 |
40 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65908565 |
41 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62106790 |
42 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.57441489 |
43 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.56301511 |
44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.54887712 |
45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53162912 |
46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49135070 |
47 | GABAergic synapse_Homo sapiens_hsa04727 | 1.47167590 |
48 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.44770940 |
49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.41789801 |
50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35824758 |
51 | RNA degradation_Homo sapiens_hsa03018 | 1.35716038 |
52 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.30650600 |
53 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28980983 |
54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26074226 |
55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25696022 |
56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.22410014 |
57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.20429446 |
58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.20388859 |
59 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14596721 |
60 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14306528 |
61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.13473673 |
62 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13003112 |
63 | Bile secretion_Homo sapiens_hsa04976 | 1.12530024 |
64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10435495 |
65 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07289166 |
66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07197037 |
67 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06639075 |
68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.03461344 |
69 | Shigellosis_Homo sapiens_hsa05131 | 1.02750237 |
70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02564926 |
71 | Asthma_Homo sapiens_hsa05310 | 1.01312557 |
72 | Retinol metabolism_Homo sapiens_hsa00830 | 1.01069492 |
73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98807296 |
74 | Morphine addiction_Homo sapiens_hsa05032 | 0.98455899 |
75 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98240434 |
76 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97798725 |
77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97232563 |
78 | Purine metabolism_Homo sapiens_hsa00230 | 0.97033212 |
79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.96706315 |
80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96483558 |
81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94616731 |
82 | Carbon metabolism_Homo sapiens_hsa01200 | 0.92268336 |
83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89441158 |
84 | Measles_Homo sapiens_hsa05162 | 0.88717373 |
85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86415186 |
86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.86118818 |
87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85125107 |
88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.84213082 |
89 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83585578 |
90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81808421 |
91 | Allograft rejection_Homo sapiens_hsa05330 | 0.79998290 |
92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77917060 |
93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.74014788 |
94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72747036 |
95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72361601 |
96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.72145355 |
97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.70483790 |
98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70204833 |
99 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.69803248 |
100 | Malaria_Homo sapiens_hsa05144 | 0.68521347 |
101 | Insulin secretion_Homo sapiens_hsa04911 | 0.68339768 |
102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.67464936 |
103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66089271 |
104 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65981215 |
105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65301022 |
106 | Salivary secretion_Homo sapiens_hsa04970 | 0.64968883 |
107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64852356 |
108 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.64800911 |
109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64501634 |
110 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.63384432 |
111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63139133 |
112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62813223 |
113 | Salmonella infection_Homo sapiens_hsa05132 | 0.62661837 |
114 | Alzheimers disease_Homo sapiens_hsa05010 | 0.62366309 |
115 | * mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61905893 |
116 | Pertussis_Homo sapiens_hsa05133 | 0.61722999 |
117 | Cocaine addiction_Homo sapiens_hsa05030 | 0.61653092 |
118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60802387 |
119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60477694 |
120 | Taste transduction_Homo sapiens_hsa04742 | 0.60402898 |
121 | Parkinsons disease_Homo sapiens_hsa05012 | 0.60219825 |
122 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.60091147 |
123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59513684 |
124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.59477735 |
125 | Prion diseases_Homo sapiens_hsa05020 | 0.57072563 |
126 | * Influenza A_Homo sapiens_hsa05164 | 0.56596712 |
127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.56536069 |
128 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55913598 |
129 | Phagosome_Homo sapiens_hsa04145 | 0.55743474 |
130 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.53656052 |
131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52970967 |
132 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52510061 |
133 | Long-term depression_Homo sapiens_hsa04730 | 0.52274719 |
134 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.51290667 |
135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50824468 |
136 | Long-term potentiation_Homo sapiens_hsa04720 | 0.50426535 |
137 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50010592 |
138 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.49920315 |
139 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.49443722 |
140 | Hepatitis B_Homo sapiens_hsa05161 | 0.49361239 |
141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.49331427 |
142 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49263468 |
143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49121905 |
144 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.47299261 |
145 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46856507 |
146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46748552 |
147 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46386657 |
148 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45984668 |
149 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.45574894 |
150 | Renin secretion_Homo sapiens_hsa04924 | 0.45179238 |
151 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.44807091 |
152 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44737103 |
153 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44617608 |
154 | ABC transporters_Homo sapiens_hsa02010 | 0.44359178 |
155 | Apoptosis_Homo sapiens_hsa04210 | 0.43283088 |
156 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42860494 |
157 | Lysosome_Homo sapiens_hsa04142 | 0.42262442 |
158 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41238126 |
159 | Mineral absorption_Homo sapiens_hsa04978 | 0.40915451 |
160 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39406027 |
161 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38380348 |
162 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.38368993 |
163 | Protein export_Homo sapiens_hsa03060 | 0.37571783 |
164 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37052616 |
165 | Platelet activation_Homo sapiens_hsa04611 | 0.36502864 |
166 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36247336 |
167 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35890527 |
168 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.34255979 |
169 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33612576 |